Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Any improvements in cholesterol profiles observed during Saxenda treatment are largely attributable to weight loss itself
One in 8 American adults now takes a GLP-1 drug to manage diabetes or obesity
As a privately owned company, we continue to invest in what matters most: our people
For patients with an A1C of 6.5% to 7.5%, metformin is the preferred initial agent, with GLP-1 receptor agonists, dipeptidyl-peptidase-4 (DPP-4) inhibitors, thiazolidinediones (TZDs), or an alpha-glucosidase inhibitor listed as viable alternatives
If Im being curious, as I want to be, I need to be open to listening and learning and actually looking at data
Understanding these behavioral dynamics is critical for pharmaceutical stakeholders assessing market retention, pricing strategies, and patient engagement models in the evolving GLP-1 landscape
US$ 24.95
US$ 29.06
US$ 28.14
US$ 28.81
US$ 24.27
US$ 20.56
